Peregrine Announces Quarterly Conference Call
...~~~ These technologies target cell structures and cell types that are common among solid tumor cancers, giving them broad applicability across various tumor types....... is currently in a multi-center Phase II clinical study for the treatment of brain cancer and in four Phase I clinical trials for the treatment of colorectal,...
Sep 05 12:01 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010905/50345.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines